Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intiland Development Tbk. (DILD) vs Merck Tbk. (MERK) Price & Performance

Intiland Development Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Intiland Development Tbk. vs Merck Tbk. — how do they compare? Intiland Development Tbk. trades at Rp115 (market cap 1.2T, 12.33M 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Intiland Development Tbk. is more actively traded (12.33M versus 33.3K). Which is the better fit depends on your goals.

DILDMERK
Market Cap
1.2T1.68T
Volume
12.33M33.3K
Lot
123.31K333
Turnover
1.42B126.46M
Average Price
115.273,797.72
Value
1.42B126.46M
Indicative Equilibrium Price
1153,800
Indicative Equilibrium Volume
339

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DILD
View details
MERK
View details

About Intiland Development Tbk.

PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.

Read more on DILD

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK